Stocks rise broadly; Pfizer rises after FDA approves vaccine
Pfizer rose after the Food & Drug Administration gave full approval to its COVID-19 vaccine.
Pfizer rose after the Food & Drug Administration gave full approval to its COVID-19 vaccine.